Corina Amor, a CSHL Fellow and CSHL Cancer Center member, made the 2022 Forbes 30 Under 30 Europe list for developing the first synthetic immune cells able to eliminate old, or senescent, cells. Senescent cells build up and can’t be removed by our bodies as we age. These cells lead to severe illnesses like cancer.
“We are hoping our work will have a lot of potential therapeutic applications,” said Amor, “both in the context of cancer, but also in the context of severe chronic pathologies such as lung or liver fibrosis.”
Amor discovered the new strategy to clean up senescent cells using reprogrammed immune cells (CAR T cells) while earning her Ph.D. at the Gerstner Sloan Kettering Graduate School of Biomedical Sciences.
Amor calls her selection by Forbes an honor. “I’m just excited and grateful that they value the work we’re doing,” she said.
Amor joined CSHL in January, 2022 as a new Ph.D. She has a M.D. from Universidad Complutense de Madrid in Spain.